Paul E. Croarkin, DO, MS

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota.

  • 12Articles
  • 58.7KReads
  • 2008–2026Active
  • 73Collaborators
  • 129Citations

About

Paul E. Croarkin, DO, MS, is affiliated with the Department of Psychiatry and Psychology at the Mayo Clinic in Rochester, Minnesota. He has contributed 12 articles to Psychiatrist.com between 2008 and 2026, focusing on topics such as child and adolescent psychiatry, depression, addiction, bipolar disorder, neuroleptic malignant syndrome, and women's mental health. He frequently collaborates with authors including Jennifer L. Vande Voort, Magdalena Romanowicz, Hannah K. Betcher, Jennifer R. Geske, and Julia Shekunov.

Publications

JCP
Next-Step Treatment Options for Treatment-Resistant Depression
Consensus Statement

Next-Step Treatment Options for Treatment-Resistant Depression

January 21, 2026

Strong consensus emerged for augmentation with second-generation antipsychotics, TMS, and ketamine/esketamine in the base vignette. Preferences shifted to include non-augmentative antidepressants and ECT based on patient characteristics.
, , , et al
JCP
Trajectories of Irritability Improvement in Depressed Adolescents Treated with 1Hz and 10Hz Transcranial Magnetic Stimulation
Original Research

Trajectories of Irritability Improvement in Depressed Adolescents Treated with 1Hz and 10Hz Transcranial Magnetic Stimulation

April 9, 2025

Irritability significantly improved during the course of both 1 Hz and 10 Hz treatments in conjunction with overall depression improvement.
, , , et al
JCP
Pilot Study of High Frequency TMS for Bipolar Depression
Original Research

Pilot Study of High Frequency TMS for Bipolar Depression

May 20, 2024

In this study of patients with bipolar depression, 87.1% reached response and 74.2% reached remission with 6 weeks of rTMS.
, , , et al
JCP
Adult Outcomes of Children With Reactive Attachment Disorder
Original Research

Adult Outcomes of Children With Reactive Attachment Disorder

October 18, 2023

Adults who had reactive attachment disorder as children had high rates of psychiatric diagnoses, substance use, suicide attempts, and psychiatric hospitalizations.
, , , et al
JCP
Toward A Definition Of “No Meaningful Benefit” From Antidepressant Treatment
Original Research

Toward A Definition Of “No Meaningful Benefit” From Antidepressant Treatment

June 27, 2022

The aim of this study was to develop and validate a categorical definition of “no meaningful benefit” from antidepressant treatment by equating percent change in scores on 3 common...
, , , et al
JCP
Original Research

Urine Drug Screens and Youth Mortality

January 11, 2022

Current practices for estimating the risk for mortality in teenage substance users rely heavily on clinical intuition. This study examined whether a positive urine drug screen in youth receiving...
, ,
PCC
Original Research

Perinatal Opioid Use and Infant Outcomes

June 10, 2021

This study compared outcomes among newborns of opioid-using and nonopioid drug–using mothers with those of control mothers who did not report substance use. Read on to find out more.
, , , et al
PCC
Original Research

Effects of Parental Opioid Use on Children

August 15, 2019

Most individuals who abuse opioids are of child-rearing age, and knowledge gaps remain regarding how this impacts their offspring. This study evaluated physical and psychiatric diagnoses of children with...
, , , et al
JCP
Article

Screening Tools in Collaborative Care of Depression

July 17, 2018

Could collaborative care be especially beneficial in certain youth with depression? Researchers enrolled patients in a collaborative care treatment model and then looked at program graduation rates in light...
, , , et al
JCP
Original Research

Genetics of Early-Onset Bipolar Disorder

February 14, 2017

Early-onset bipolar disorder may represent a distinct phenotype with greater severity, but the genetics of it are still poorly understood. This study used candidate genetic risk score analysis to...
, , , et al
JCP
Article

Adjunctive Use of Repetitive Transcranial Magnetic Stimulation in Depressed Adolescents: A Prospective, Open Pilot Study

September 15, 2011

, , , et al
JCP
Article

Neuroleptic Malignant Syndrome Associated With Atypical Antipsychotics in Pediatric Patients: A Review of Published Cases

July 31, 2008

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe